Stilla Technologies is a Life sciences company whose mission is to improve health by offering researchers and clinicians worldwide solutions for high precision genetic analysis.
Since 2016, Stilla Technologies has empowered researchers with the naica® system, a solution that enables to detect & quantify nucleic acid with unprecedented precision.
The naica® system supports a wide range of genetic tests and molecular biology assays — including liquid biopsy tests for cancer diagnostics, viral load quantification, GMO detection, etc… Overall, the naica® system superior performances make it a preferred technology for precision medicine research and therapeutic monitoring.
Stilla® advises and supports its customers worldwide with a multidisciplinary team, whose expertise spans from microfluidics and chemistry to molecular biology and computer science. Stilla’s talented and multidisciplinary team shares a passion for building successful Life Science and Diagnostic products based on deep technological innovations.
